- Home
- PMVP
as 07-26-2024 4:00pm EST
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | 81.8M | IPO Year: | 2020 |
| Target Price: | $5.75 | AVG Volume (30 days): | 542.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.18 - $9.72 | Next Earning Date: | 08-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest PMV Pharmaceuticals Inc. News
PMVP Breaking Stock News: Dive into PMVP Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 months ago
Enhancing the Power of PTZs: Canon Announces New PTZ Firmware Updates Lending Greater Control and Operability, Including an Auto-Tracking Lite Version on Compatible PTZ Models*
PR Newswire
2 months ago
NexTech Solutions Has Agreed to Acquire Rome Research Corporation to Expand Service Offerings and Enhance Mission Support Capabilities
Business Wire
2 months ago
Form 8.3 - Darktrace plc
Business Wire
2 months ago
Form 8.3 - International Distribution Services plc
Reuters
2 months ago
US Supreme Court rejects Kroger challenge to Grubhub trademark win
Investor's Business Daily
2 months ago
Dow Jones Falls As AMD Slides On Downgrade; Nvidia Stock Split Takes Effect
Business Wire
2 months ago
GoldATM Supports Growing Consumer Demand for Gold Purchase with New ATMs in North Carolina
GlobeNewswire
2 months ago
Middlefield Canadian Income PCC: Net Asset Value(s)
Compare PMVP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PMVP PMV Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.